Trial Profile
A Study to Evaluate the Efficacy and Safety of Rituximab in Patients With Refractory Active Rheumatoid Arthritis (RA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms MIRA
- 29 Dec 2015 New trial record